PMD - Rasio utang marang kapitalisasi buku Psychemedics Inc

Logo grafis Psychemedics (PMD)

The investment potential of Psychemedics (PMD) is bolstered by the robotization of hair analysis, which eliminates human error. The ratio of attracted funds to book capitalization demonstrates leverage dynamics, with the indicator standing at 0.32. Business stability is ensured by testing drivers and port workers to secure logistics safety, as well as a strategy for B2B client retention through the digital optimization of laboratory processes.

Psychemedics - Utang-utang marang kapitalisasi buku PMD (periode 04.07.2022 - 21.12.2024)
Barang unggulan Psychemedics Corp

Reducing debt risks is a priority in the fundamental analysis of Psychemedics (PMD). Stable cash flow from the mature hair analysis segment minimizes the business's reliance on external borrowings. This indicator compares total liabilities with the market value of capital, as reflected in the total debt-to-book capitalization ratio. This metric's trend captures the current investor reassessment of the credit load. The decline in this value confirms financial stability but may signal conservative capital management.

Karo sapa Psychemedics saingan

Utang-utang marang kapitalisasi buku A (Agilent Technologies)|questdiagnostics.com - Utang-utang marang kapitalisasi buku|Illumina (ILMN) - Rasio utang marang kapitalisasi buku|EXAS - Rasio utang marang nilai buku|RVTY: Utang-utang marang kapitalisasi buku|BIO (Bio-Rad Corp) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Anbio Biotechnology|Rasio utang marang kapitalisasi buku soterahealth.com (SHC)|QuidelOrtho Corporation - Utang marang nilai buku|Utang-utang marang nilai buku OPK (OPKO Health Inc)|Rasio utang marang kapitalisasi buku CDNA|Utang-utang marang aset resik Maravai MRVI|Utang-utang marang kapitalisasi buku FLGT (Fulgent Genetics, Inc.)|LAB: Utang-utang marang aset resik|Cytek Biosciences - Rasio utang marang kapitalisasi buku|OSUR (OraSure Technologies, Inc.) - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Exagen Inc XGN|Rasio utang-utang marang kapitalisasi buku MDXH|LUCD (Lucid Diagnostics Inc.) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik prenetics.com PRE|IMDX: Utang marang nilai buku|Utang-utang marang nilai buku Trinity Biotech PLC TRIB|PRPH: Utang-utang marang kapitalisasi buku|AIMD - Utang marang nilai buku|Utang-utang marang kapitalisasi buku Co-Diagnostics, Inc. CODX|heartsciences.com (HSCS) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku BMRA (Biomerica)|Utang-utang marang nilai buku CDIO|Rasio utang marang kapitalisasi buku VRAX (Virax Biolabs Group Ltd)|Utang marang nilai buku Bluejay Diagnostics Corp (BJDX)|AWH: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku acceleratediagnostics.com AXDX|CENTOGENE (CNTG) - Utang-utang marang kapitalisasi buku|ENZ - Rasio utang marang nilai buku|fresh2.co - Utang-utang marang kapitalisasi buku|Genetic Technologies Limited (GENE) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ME